-
公开(公告)号：US20200345819A1
公开(公告)日：2020-11-05
申请号：US16272998
申请日：2019-02-11
摘要： Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purified botulinum neurotoxin, a carrier and a viscosity modifier to one or more inner surfaces of the nose. The methods disclosed herein provide alternative methods for delivery of botulinum neurotoxin to the nasal anatomy for the treatment of rhinitis.
-
公开(公告)号：US20140120077A1
公开(公告)日：2014-05-01
申请号：US14065379
申请日：2013-10-28
IPC分类号： A61K38/48
CPC分类号： A61K38/4893 , A61K9/0043 , A61K38/48 , A61K47/10 , A61K47/34 , A61K47/42 , A61M31/00 , C12Y304/24069
摘要： Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purified botulinum neurotoxin, a carrier and a viscosity modifier to one or more inner surfaces of the nose. The methods disclosed herein provide alternative methods for delivery of botulinum neurotoxin to the nasal anatomy for the treatment of rhinitis.
摘要翻译： 本文提供了治疗受试者鼻炎的方法。 本发明的方法包括鼻内施用包含纯化的肉毒杆菌神经毒素，载体和粘度调节剂到鼻子的一个或多个内表面的局部组合物。 本文公开的方法提供用于将鼻内神经毒素递送至用于治疗鼻炎的鼻解剖体的替代方法。
-
公开(公告)号：US20200215357A1
公开(公告)日：2020-07-09
申请号：US16656115
申请日：2019-10-17
摘要： This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the invention exhibit one or more advantages over conventional botulinum toxin formulations, including reduced antigenicity, a reduced tendency to undergo unwanted localized diffusion following injection, increased duration of clinical efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or improved stability.
-
公开(公告)号：US10201594B2
公开(公告)日：2019-02-12
申请号：US15155551
申请日：2016-05-16
IPC分类号： A61K39/08 , A61K39/00 , A61K39/38 , A61K38/48 , A61K9/00 , A61K47/10 , A61K47/34 , A61K47/42 , A61M31/00
摘要： Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purified botulinum neurotoxin, a carrier and a viscosity modifier to one or more inner surfaces of the nose. The methods disclosed herein provide alternative methods for delivery of botulinum neurotoxin to the nasal anatomy for the treatment of rhinitis.
-
公开(公告)号：US20180214717A1
公开(公告)日：2018-08-02
申请号：US15937388
申请日：2018-03-27
CPC分类号： A61Q19/08 , A61K8/64 , A61K2800/592 , A61K2800/91
摘要： This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the invention exhibit one or more advantages over conventional botulinum toxin formulations, including reduced antigenicity, a reduced tendency to undergo unwanted localized diffusion following injection, increased duration of clinical efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or improved stability.
-
公开(公告)号：US20160250302A1
公开(公告)日：2016-09-01
申请号：US15155551
申请日：2016-05-16
CPC分类号： A61K38/4893 , A61K9/0043 , A61K38/48 , A61K47/10 , A61K47/34 , A61K47/42 , A61M31/00 , C12Y304/24069
摘要： Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purified botulinum neurotoxin, a carrier and a viscosity modifier to one or more inner surfaces of the nose. The methods disclosed herein provide alternative methods for delivery of botulinum neurotoxin to the nasal anatomy for the treatment of rhinitis.
摘要翻译： 本文提供了治疗受试者鼻炎的方法。 本发明的方法包括鼻内施用包含纯化的肉毒杆菌神经毒素，载体和粘度调节剂到鼻子的一个或多个内表面的局部组合物。 本文公开的方法提供用于将鼻内神经毒素递送至用于治疗鼻炎的鼻解剖体的替代方法。
-
公开(公告)号：US11471708B2
公开(公告)日：2022-10-18
申请号：US16656115
申请日：2019-10-17
摘要： This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the invention exhibit one or more advantages over conventional botulinum toxin formulations, including reduced antigenicity, a reduced tendency to undergo unwanted localized diffusion following injection, increased duration of clinical efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or improved stability.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.021 秒)